We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$64.3M
2
RHT
Red Hat Inc
RHT
+$57.1M
3
TSS
Total System Services, Inc.
TSS
+$40M
4
WP
Worldpay, Inc.
WP
+$39.2M
5
LLL
L3 Technologies, Inc.
LLL
+$32M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
2926
Liquidia Corp
LQDA
$7.95B
$48K ﹤0.01%
13,400
-125
-0.9% -$739
AEG icon
2927
Aegon
AEG
$14B
$46K ﹤0.01%
+12,043
New +$48K
LYG icon
2928
Lloyds Banking Group
LYG
$90B
$46K ﹤0.01%
17,271
+5,826
+51% +$15.1K
ROAN
2929
DELISTED
Roan Resources, Inc.
ROAN
$44K ﹤0.01%
36,145
+4,915
+16% +$6.4K
CKPT
2930
DELISTED
Checkpoint Therapeutics
CKPT
$42K ﹤0.01%
1,701
+15
+0.9% +$412
ECOR icon
2931
electroCore
ECOR
$60.4M
$42K ﹤0.01%
1,269
+91
+8% +$2.88K
SER icon
2932
Serina Therapeutics
SER
$35.2M
$42K ﹤0.01%
615
-6
-1% -$569
PHAS
2933
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$42K ﹤0.01%
10,182
-125
-1% -$997
CHAP
2934
DELISTED
Chaparral Energy, Inc.
CHAP
$42K ﹤0.01%
31,601
+4,350
+16% +$12K
METC icon
2935
Ramaco Resources Class A
METC
$608M
$41K ﹤0.01%
11,416
+995
+10% +$4.29K
IMDX
2936
Insight Molecular Diagnostics
IMDX
$155M
$37K ﹤0.01%
892
-10
-1% -$393
NTGN
2937
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$37K ﹤0.01%
21,720
+1,850
+9% +$5.63K
NCSM icon
2938
NCS Multistage Holdings
NCSM
$128M
$34K ﹤0.01%
854
+91
+12% +$4.63K
USWS
2939
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$34K ﹤0.01%
738
+13
+2% +$855
CHGA
2940
Change Agents Corporation Common Stock
CHGA
$2.68M
$31K ﹤0.01%
109
+5
+5% +$1.57K
VBIV
2941
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$30K ﹤0.01%
2,122
+98
+5% +$2.05K
CTRC
2942
DELISTED
Centric Brands Inc. Common Stock
CTRC
$30K ﹤0.01%
11,911
-175
-1% -$489
CHRA
2943
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$28K ﹤0.01%
1,324
+124
+10% +$4.89K
UMC icon
2944
United Microelectronic
UMC
$48.2B
$24K ﹤0.01%
+11,474
New +$24.5K
PHUN icon
2945
Phunware
PHUN
$44.6M
$20K ﹤0.01%
+277
New +$24.2K
FBRX icon
2946
Forte Biosciences
FBRX
$1.57B
$18K ﹤0.01%
72
– –
GSAT icon
2947
Globalstar
GSAT
$10.7B
$13K ﹤0.01%
2,060
– –
SKYS
2948
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$5K ﹤0.01%
+4,189
New +$5.4K
BLRX
2949
BioLineRX
BLRX
$12.1M
– –
-21
Closed -$5K
CBUS icon
2950
Cibus
CBUS
$143M
– –
-201
Closed -$126K
116 117
118
119 120

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.